Group items tagged

Nutritional supplements are any dietary supplement that is used to treat nutritional deficiencies in the body. Nutritional supplements are intended to provide nutrients that may otherwise not be consumed in sufficient quantities, for instance, amino acids, proteins, minerals, vitamins, or other nutritional ingredients. Products are usually ingested in liquid, tablet, or capsule form. However, at certain times in life, many individuals often need more trace elements, minerals, vitamins, etc. That's when it is a good time to take supplements. The health benefits associated with nutritional supplements are improved cardiovascular health and reduction in signs of aging among others. Increasing prevalence of chronic diseases (such as diabetes, cancer, and heart disease) and the growing geriatric population worldwide is expected to drive the growth of the nutritional supplements market. According to the Centers for Disease Control and Prevention (CDC), chronic diseases are the leading causes of death and disability in the United States. Moreover, growing awareness among people about the benefits of dietary supplements is also expected to propel the market growth. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/growing-awareness-about-benefits-of.html

A lot of claims are made about the positive effects of supplements on vision and eye health, but very few research studies support these claims. Eye health supplements contain vitamins and other nutrients that are beneficial for maintaining eye health and good vision. These supplements are designed to add to nutrients, not replace. Eye health supplements are also consumed to nullify the impact of infections and eye diseases. Cataract affects more than 24.4 million people (age 40 and older) in the United States or about one in every six people in this age range. While, in Italy, there has been a 10% annual increase in cataract surgery procedures. In 2017, around 1,130 individuals out of 100,000 were suffering from cataracts in Italy. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/eye-health-supplements-help-slow-or.html

One of the most popular brain supplements is called Brain Fitness Premium, which boosts the level of fatty acids in your brain. The fatty acids boost brain function by increasing blood flow to the brain and improving neurotransmitter levels, both of which are important to brain function. Other popular brain supplements include: Brain Power Plus, Brain Boosters, Ginkgo Biloba, and Hops Strawns. All of these ingredients are proven to help improve brain function and reduce the risk of Alzheimer's. Increasing prevalence of neurological disorders is expected to propel growth of the brain health supplements market. For instance, according to Alzheimer's Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Moreover, launch of new products is also expected to aid in growth of the market. For instance, in January 2020, InnerScope Hearing Technologies Inc. launched its new Brain Health & Dietary Hearing Supplement on Walmart.com. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-prevalence-of-neurological.html

Multivitamins as the name suggests means an aggregation of more than three vitamins together required in small quantity. Mindful healthy people rely on multivitamin supplement so that their body can get the right nutrients for its appropriate functioning. Multivitamins are basically devoted to prevent the dearth of minerals as well as vitamins which provides the body with a number of benefits like it maintains bone health, teeth, structural health, blood cells, and deficiency like vitamin C causes Scurvy etc.

Buy Omega-3 Supplements EpaMax Online. The levels of EPA and DHA within EpaMax provide sufficient amounts to your diet to enhance your overall emotional and physical wellbeing. Chemist Direct offers EpaMax Omega-3 Capsules at discounted prices. Save up to 70% on high street prices.

Discover the medicare advantage and get the facts you need to know to live a happy and healthier life by requesting a medicare supplemental quote.

Arthrella is a rich combination of joint support phytochemicals. Arthrella combines the extracts of 4 herbs which offer support to the bones and the joints and help regulate healthy active joints and muscles. Arthrella helps in promoting normal structure and functioning of musculoskeletal system Social Media Site https://www.youtube.com/user/CharakPharma https://www.facebook.com/CharakPharma https://twitter.com/charak_pharma https://plus.google.com/+charakpharma https://www.linkedin.com/company/charak-pharma-pvt.-ltd. https://www.pinterest.com/OTCSupermarket/charak-pharma/ https://plus.google.com/u/0/communities/112690639266834894016 CONTACT US Charak Pharma (USA) inc 303-5th Avenue, Suite # 1007 New York, NY 10016 United States Website- http://www.charakusa.com/ Email : enquiry@charakusa.com info@charakusa.com 91 22 33016734 Google My Business Location- http://listings.findthecompany.com/l/474216049/Charak-Pharma-Usa-Inc-in-New-York-NY Buy Innoveda Arthrella Online - Shop, Cart & checkout Page Url Shop - http://www.charakusa.com/shop/ Add to Card - http://www.charakusa.com/cart/ Proceed to Checkout- http://www.charakusa.com/checkout/

Dextrin is a complex carbohydrate polymer in which one sugar molecule pairs with another through a peptide bond. The term comes from the fact that each sugar molecule has a double bond between the glucose and amino group. The sugar in the hexose sugars (glucose) and the forward bend of the double bond is called 'dextrin', whereas the non-amylated sugar is called 'xtrin' or simply 'x'. The purpose of this carbohydrate polymer is to create a complex, rather than simple sugar. Dextrin was initially developed to replace sucrose as a food supplement (in the food industry) and for medical purposes. Dextrin contains many similar properties to both glucose and maltodextrin and it was often used as an ingredient to replace sugar in diabetic diets (since diabetic diets typically do not contain the complex carbohydrates that provide the bulk of dietary fiber). Moreover, dextrin has the advantage of resembling both maltodextrin and glucose and many diabetics find that their oral medications contain dextrin instead of glucose Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/dextrin-has-similar-properties-to-both.html

Nutraceuticals are items that fall under the food category but have medical uses as well. Given that they are created using food and food extracts, they are also referred to as bioceuticals. Nutraceutical products come in a wide range of varieties and are used for a variety of purposes. These goods are unregulated in many parts of the world because they are viewed as food additives or supplements. Products made with nutraceuticals are in high demand. The growing knowledge of the health advantages associated with the intake of nutraceuticals and Nutraceutical supplements is the main driver of the increase in demand for these products. Additionally, it is anticipated that increased athlete participation in sports at the national and international levels will raise demand for functional beverages. The market for functional foods is expanding primarily due to rising cardiovascular, chronic, and obesity-related disorders as well as an urbanizing population, rising healthcare spending, and these diseases. Omega fatty acids, which are abundant in functional foods, aid to regulate blood circulation and maintain weight. It offers medical or health advantages, such as disease prevention and treatment. Due to the increasing prevalence of lifestyle-based diseases in the UAE, which is brought on by excessive packaged food consumption and a sedentary lifestyle, the need for nutraceuticals in the form of fortified functional foods and beverages has grown over time.

Overview: Drug and device research is confusing and difficult on its own but when you start combining drugs with devices the regulatory landscape changes as there are more nuances to deal with. Knowing how drug and device studies are each regulated is important in navigating the challenges posed by studies that wish to use both. It is also important to be aware of current guidance affecting the use of both drugs and devices in a study as well current guidance affecting the classification of devices. Why should you attend: Information on drugs and devices is plentiful. But, it can also be daunting .The webinar will give attendees a foundation and a starting point on which they can build. Learning objectives: Define drug research Define device research Explore the differences between the two Describe requirements when drugs and devices are combined in one study Areas Covered in the Session: Defining Drug Research FDA approved drugs Investigational drugs Compassionate use Defining Device Research FDA approved devices 510 K devices Humanitarian Device Exemptions Invitro Diagnostic Devices Investigational Devices Federal regulations governing drugs and devices Guidance governing drugs and devices Combining devices and drugs into one study What are the requirements? What are the regulations and guidance? How these studies are reviewed Who Will Benefit: Investigators Researchers Research Staff Study Coordinators Auditors Research Administrators Speaker Profile Sarah Fowler-Dixon is Education Specialist and instructor with Washington University School of Medicine. She has developed a comprehensive education program for human subject research which has served as a model for other institutions. She crafted budgets, policies, procedures, reporting, and training for the new program. She has initiated the planning, development, authorship and implementation of many human subjects research policies, practices, guidelines, submission and reviewer forms often working with st

Overview: The trial master file is a hard copy of all documentation relating to a clinical trial. It contains essential documents. When studies are conducted under ICH E6 Good Clinical Practices (GCP), this collection of documents must be present before, during and after the trial. These documents help provide quality assurance and help researchers evaluate their compliance with GCP, federal regulations and applicable laws. Why should you Attend: Anyone responsible for handling trial documentation or quality assurance activities. Areas Covered in the Session: Trial Master File (TMF): what is it? Essential documents required ICH guidelines and Good Clinical Practice (GCP) Food and Drug Administration (FDA) guidance and expectations Paper or electronic trial master files - what is allowable Links to useful resources Who Will Benefit: This webinar will provide valuable assistance to all personnel in: Human Subjects Research Healthcare interested in exploring the field of Clinical Research New Clinical Research Coordinator positions (1-2 years) New Principal Investigator positions Administration in charge of Clinical Research Regulatory Compliance Speaker Profile Sarah Fowler-Dixon is Education Specialist and instructor with Washington University School of Medicine. She has developed a comprehensive education program for human subject research which has served as a model for other institutions. She crafted budgets, policies, procedures, reporting, and training for the new program. She has initiated the planning, development, authorship and implementation of many human subjects research policies, practices, guidelines, submission and reviewer forms often working with state and federal authorities. She has provided consultation regarding ethical, federal, state, and institutional requirements for faculty and staff both in the design and execution of their projects and teaches research ethics and regulatory affairs and the fundamentals of research manageme

Workplace Safety Regulations : Workplace safety is a matter of grave importance to any organization. Ensuring the safety of workers is a primary goal of most countries, no matter which kind of political system or setup they have. This is because almost no workplace is free from some or another kind of hazard. These workplaces could be as varied as hospitals, construction sites, engineering plants or agriculture and many more. Governments the world over consider it their duty to provide a safe workplace. Workplace safety can concern any hazard that can happen to either the physical or emotional wellbeing of a worker. National and global workplace safety regulations : Workplace safety regulations are legally stipulated measures that governments require organizations in both the private and public sector to implement in order to ensure safety at the workplace. Almost all countries have their own set of workplace safety regulations. These regulations work in tandem with a few global management systems with the aim of enhancing safety standards at the workplace. A notable global organization that is at the forefront of legislating workplace safety regulations is the International Labor Organization (ILO). These ILO-mandated legislations are meant to supplement the national workplace safety regulations that most countries have. This is done in the belief that many a time, these individual legislations may not be sufficient in themselves. Workplace safety regulations in the US : Like most other countries, the US too has its own set of Occupational Safety and Health (OSH) standards. Owing their origins to the Richard Nixon era in late 1970; workplace safety regulations in the US concretized under what is collectively called the Occupational Safety and Health Administration (OSHA). The major feature of OSHA is that apart from promulgating workplace safety regulations across nearly all conceivable sectors and types of industries; OSHA also has a provision for whistleblow

Course "Marketing Products without Getting Hammered by FDA" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: With this seminar you will learn how to navigate FDA's legal requirements and its interpretations for enforcement purposes. The agency now applies the principles of cognitive psychology to aid in its determination of what a message really conveys. This becomes a new factor in trying to stay within FDA's legal corral. This conference will provide insight on how to manage your marketing activity and gauge what regulatory risks your business is willing to accept. You will learn how corporate management requires cooperation between marketing, regulatory affairs, legal counsel, manufacturing, engineering and finance departments. You will understand that a weak link in any department leaves the entire corporation vulnerable to FDA enforcement. Most importantly, you will understand the boundaries that FDA uses and how easy it is to cross them. With information from this course, you can step back and rationally evaluate your firm's regulatory profile for advertising and promotion. Why should you attend: If you go "off label" with advertising and promotion, you become embroiled in FDA's advertising and promotion requirements. For devices, the law is weak and lacks legal clarity. For drugs, FDA's law and regulations are extensive and have violated Constitutional protections. Depending on your point of FDA's promotion and advertising requirements can help you or hurt you? There is an inherent conflict in interests. In any case, you need to identify practical criteria to make marketing decisions. That begs the question of whether or not marketing managers and regulatory affairs managers will even try to agree on an issue. FDA's Center for Devices and Radiological Health (CDRH) has never issued a comprehensive guidance on advertising and promotion. You are on your own. CDER has esta

Overview: FDA 7348.811 section 1 states, "Regardless of the type of system used by the clinical site, the regulatory requirements for clinical data do not change whether clinical data are captured on paper, electronically, or using a hybrid system." What type of system is best for your program and investigator capabilities? The wrong choice yields inspectional non compliance. The right choice of electronic data capture, direct data entry, and data management depends on a sponsor assessment of the systems and procedures at the investigator site as compliant with FDA inspectional requirements. Additional source documentation procedures (origination, authorization, and signature) are required at the investigator site to address the electronic data capture process. It is these three FDA mandated inspectional criteria, applicable to every electronic data element, that generate most of the significant inspectional noncompliant findings. Some data elements are more likely to be associated with the findings of noncompliance than others. It is in fact difficult to determine which data requires or does not require original source documentation and what defines "original source documentation". Why should you attend: Investigators commonly assume that the new guidance and regulations reduce the need for source documentation in clinical trials. In fact, there are new procedural documents relevant to the electronic source documents and direct data entry that are required to comply with the current inspectional standards and the final guidance. Sponsor due diligence in choosing, training, and monitoring investigator sites to enable the use of compliant electronic data capture is required. Basic knowledge of part 11 and GCP requirements will be helpful in attending this advanced webinar. The focus will be on the additional FDA inspectional requirements for electronic data capture, and the impact of using electronic data capture on the seven FDA inspectional priority objectives

Omega-3 fatty acids present in fish oil play a significant role in enhancing health of men. Decreased intake of omega-3 fatty acid and circulating range of DHA (Docosahexaenoic acid) in the body of men leads to the risk of enlarged prostate or BPH (Benign Prostatic Hyperplasia), prostatitis or prostate cancer.

Overview: The Sunshine Act, or Open Payments Program, requires manufacturers of drugs, medical devices, and biologics that participate in U.S. federal health care programs to report certain payments and items of value given to physicians and teaching hospitals. This Act was part of a healthcare reform bill adopted in March 2010. It came about due to requests for increased transparency about the financial relationships between physicians and industry. The Centers for Medicare and Medicaid (CMS) issued the final rules in 2013 which implemented the Sunshine Act. Why should you Attend: Anyone required to adhere to the Sunshine Act standards or anyone interested in knowing what must be reported and made public. Areas Covered in the Session: Purpose of the Sunshine Act Who is required to report under the Sunshine Act? What is reported? Exclusions Tracking Penalties Useful links Who Will Benefit: This webinar will provide valuable assistance to all personnel in: Human Subjects Research Healthcare interested in exploring the field of Clinical Research Clinical Research Coordinators Principal Investigators/Physicians Administration in charge of Clinical Research Regulatory Compliance Speaker Profile Sarah Fowler-Dixon is Education Specialist and instructor with Washington University School of Medicine. She has developed a comprehensive education program for human subject research which has served as a model for other institutions. She crafted budgets, policies, procedures, reporting, and training for the new program. She has initiated the planning, development, authorship and implementation of many human subjects research policies, practices, guidelines, submission and reviewer forms often working with state and federal authorities. She has provided consultation regarding ethical, federal, state, and institutional requirements for faculty and staff both in the design and execution of their projects and teaches research ethics and regulatory affairs and the fu

Vitamin b12 called cobalamine, important for vital functions in body, like maintenance. Deficiency cause malnutrition and digestion problems. Treatments including supplements, injections and vitamins regulatory measures.